Topic Hub
12 clinically reviewed articles, written and peer-reviewed by the HealthRX.com Medical Team.
Explore
Showing 12 of 12 clinical reviews.
A clinician-reviewed guide to how Vyvanse (lisdexamfetamine) affects growth, brain development, sleep, cardiovascular health, and substance risk in adolescents aged 12-17, with cited trial data and dosing guidance.
Read clinical reviewA clinician-reviewed guide to off-label Vyvanse use in adolescents ages 12 to 17, covering binge eating disorder, depression augmentation, and fatigue, with trial data, dosing, and safety considerations.
Read clinical reviewA clinician-reviewed guide to prescribing Vyvanse (lisdexamfetamine) in patients 65 and older, covering geriatric pharmacokinetics, cardiovascular risk, dose titration, and transition from pediatric or young-adult care.
Read clinical reviewA clinician-reviewed guide to off-label Vyvanse (lisdexamfetamine) use in adults 65 and older, covering pharmacokinetics, cardiovascular risk, ADHD evidence, renal dosing, and safer prescribing strategies for geriatric patients.
Read clinical reviewEverything families and clinicians need to know about managing Vyvanse therapy in children under 12 and planning a safe, evidence-based handoff to adult care.
Read clinical reviewA physician-reviewed guide for caregivers on administering Vyvanse (lisdexamfetamine) to adolescents ages 12 to 17, covering dosing, timing, monitoring, safety, and what to watch for.
Read clinical reviewA clinician-reviewed guide to lisdexamfetamine (Vyvanse) use in adolescents aged 12 to 17, covering academic performance, sports participation, sleep, appetite, and school accommodation planning.
Read clinical reviewA clinician-reviewed guide to transitioning adolescents on Vyvanse (lisdexamfetamine) to adult ADHD care, including dosing, monitoring, insurance, and what to expect at age 18.
Read clinical reviewA clinician-reviewed guide to administering Vyvanse (lisdexamfetamine) to children under 12, covering FDA-approved dosing, mixing instructions, food interactions, missed doses, storage, and safety monitoring.
Read clinical reviewA clinician-reviewed guide to lisdexamfetamine (Vyvanse) use in patients 65 and older, covering pharmacokinetics, cardiovascular risk, cognitive effects, dosing, and the limited evidence base for this age group.
Read clinical reviewA clinician-reviewed guide to managing Vyvanse (lisdexamfetamine) in children under 12, covering classroom performance, after-school activities, dosing timing, appetite, and safety monitoring.
Read clinical reviewA physician-reviewed guide to the developmental effects of Vyvanse (lisdexamfetamine) in children under 12, covering growth, brain development, behavior, and long-term safety evidence.
Read clinical review